Transfusion and Haematology Today - Issue 4/2019
Review/Educational Papers
291
Genome editing using the CRISPR/Cas9 system and its application in haematology
M. Racková, V. Bakardjieva-Mihaylova, M. Slámová, L. Boublíková, K. Škvárová Kramarzová
301
310
320
Denosumab and bisphosphonates in multiple myeloma in 2019
Z. Král, Z. Adam, M. Krejčí, L. Pour, V. Sandecká, M. Štork
331
Mutations of the RAS family in patients with acute myeloid leukaemia
A. Ďuriníková, A. Folta, M. Čulen, Z. Herudková, D. Al Tukmachi, J. Mayer, I. Ježíšková
Original Papers
340
Characteristics and results of the treatment of patients with acute myeloid leukaemia ≥ 60 years – data from the CELL DATOOL AML database
Z. Šustková, L. Semerád, J. Procházková, P. Cetkovský, P. Žák, J. Novák, T. Szotkowski, Z. Kořístek, L. Burešová, J. Mayer, Z. Ráčil
350
Bone marrow harvesting for allogeneic transplantation – evaluation of ten years’ experience focusing on donor auto-transfusion utilisation
L. Hejretová, D. Lysák, M. Hrabětová, P. Jindra
Transfusion and Haematology Today
2019 Issue 4
Most read in this issue
- Genome editing using the CRISPR/Cas9 system and its application in haematology
- Characteristics and results of the treatment of patients with acute myeloid leukaemia ≥ 60 years – data from the CELL DATOOL AML database
- Complex mechanisms of action of „BCR signalling“ inhibitors and development of resistance to this targeted therapy in chronic lymphocytic leukaemia
- Mutations of the RAS family in patients with acute myeloid leukaemia